Cancer Research concerned that campaign,funded by treatment manufacturer, will mislead women before official menopause guidance is releasedA PR campaign to promote the utilize of hormone replacement therapy in women is under way before official guidance on how to treat the menopause is released, or causing some scientists concern that the cancer dangers of the drugs will be underplayed.
The campaign,run by the Weber Shandwick agency and funded by a drug manufacturer that provides the treatment, has already keep out a survey saying women are unnecessarily worried about the risks of HRT. It is preparing a further release about the attitudes of GPs to prescribing the drugs. Continue reading...
Source: theguardian.com